Literature DB >> 23842020

Tools to assess negative symptoms in schizophrenia.

John M Kane1.   

Abstract

Although effective treatments for negative symptoms are currently limited, clinicians still need to assess and monitor them because of their impact on patient functioning. Further, documenting patients' negative symptoms provides a complete clinical record that the clinician can use to make systematic and careful treatment decisions. Several tools for assessing negative symptoms in schizophrenia are available, including the Clinical Global Impression scale (CGI), the Brief Psychiatric Rating Scale (BPRS), the Positive and Negative Syndrome Scale (PANSS), the Scale for the Assessment of Negative Symptoms (SANS), the 16-item Negative Symptoms Assessment (NSA-16), and the Schedule for Deficit Syndrome (SDS). Additionally, newer instruments are in development-the Clinical Assessment Interview for Negative Symptoms (CAINS) and the Brief Negative Symptoms Scale (BNSS)-and are yielding promising results. This overview outlines these assessment tools so that clinicians can measure negative symptom severity and track treatment response for their patients with schizophrenia. © Copyright 2013 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23842020     DOI: 10.4088/JCP.12045tx2c

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  Neuromodulation Treatments for Schizophrenia.

Authors:  Mehmet E Dokucu
Journal:  Curr Treat Options Psychiatry       Date:  2015-07-03

Review 2.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

3.  Comparative Analysis of Gene Expression Profiles Involved in Calcium Signaling Pathways Using the NLVH Animal Model of Schizophrenia.

Authors:  Alma Genis-Mendoza; Ileana Gallegos-Silva; Carlos Alfonso Tovilla-Zarate; Lilia López-Narvaez; Thelma Beatriz González-Castro; Yazmín Hernández-Díaz; Mavil López-Casamichana; Humberto Nicolini; Sandra Morales-Mulia
Journal:  J Mol Neurosci       Date:  2017-12-06       Impact factor: 3.444

4.  An Assessment of Five (PANSS, SAPS, SANS, NSA-16, CGI-SCH) commonly used Symptoms Rating Scales in Schizophrenia and Comparison to Newer Scales (CAINS, BNSS).

Authors:  Suneeta Kumari; Mansoor Malik; Christina Florival; Partam Manalai; Snezana Sonje
Journal:  J Addict Res Ther       Date:  2017-05-11

5.  Non-verbal speech cues as objective measures for negative symptoms in patients with schizophrenia.

Authors:  Yasir Tahir; Zixu Yang; Debsubhra Chakraborty; Nadia Thalmann; Daniel Thalmann; Yogeswary Maniam; Nur Amirah Binte Abdul Rashid; Bhing-Leet Tan; Jimmy Lee Chee Keong; Justin Dauwels
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

6.  Are negative symptoms in schizophrenia a distinct therapeutic target?

Authors:  Octavia Oana Capatina; Ioana Valentina Miclutia
Journal:  Clujul Med       Date:  2018-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.